The current price of ESPR is $3.18 — it has remained unchanged since the previous close. Data as of Jul 13, 2026.
ESPR is flat over the past week, flat over the past month and up 77.65% over the past year. The price is above its 200-day moving average of $3.09.
Esperion Therapeutics, Inc. has a market capitalization of $661.15M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Companies most comparable to Esperion Therapeutics, Inc. include PTC Therapeutics, Inc., Agios Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Emergent BioSolutions Inc. and Heron Therapeutics, Inc.
In the latest trading session ESPR moved between $3.18 and $3.18, a range of 0.00% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Esperion Therapeutics, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ESPR has traded between $1.80 and $4.18. The current price is 23.92% below its 52-week high.
Figures as of Jul 13, 2026. This information is provided for general purposes only and is not investment advice.